This inventor holds 203 USPTO granted patents, primarily in Pharmaceutical Chemistry (CPC class 424180). Top assignees: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Nippon Kayaku Kabushiki Kaisha, Sanraku-Ocean Co., Ltd.. Active years: 1976-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Tokyo, JA (1976 - 1978)
- late of Tokyo, JP (1989)
- Tokyo, JP (1978 - 1994)
Company Filing History:
143 out of 212 
13 out of 801 
13 out of 37 
Years Active: 1976-1994
Areas of Expertise:
Title: Hamao Umezawa: Pioneering Innovator and Inventor in Tokyo, Japan
Introduction:
Hamao Umezawa, a prominent inventor hailing from Tokyo, Japan, has made significant contributions to the world of pharmaceuticals through his groundbreaking patents. With an impressive portfolio of 203 patents, Umezawa’s innovative solutions have revolutionized the field of medicinal chemistry. In this article, we will delve into some of his latest patents, highlight his career achievements, explore his collaborations, and recognize the impact he has made within the industry.
Latest Patents:
Umezawa’s recent patents showcase his ingenuity and ability to develop novel compounds with therapeutic applications. One such patent is titled "N-methylphenylserine alkyl ester derivatives and uses thereof." This patent introduces new compounds that act as effective alpha and beta adrenergic agents for stimulating the central nervous system's functions. These compounds hold great potential for treating disorders related to reduced activity in alpha and beta neuronal functions. Notably, N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine (C1-C6) alkyl esters are among the preferred compounds in this invention.
Another notable patent by Umezawa is on "Mycaminosyl tylonolide derivatives." These compounds, represented by a well-defined chemical structure, hold promise for various therapeutic applications. Their potential to be used as medicinal agents can be attributed to their unique properties and the presence of specific functional groups within their structure. These derivatives have opened up new possibilities in the field of pharmaceutical research.
Career Highlights:
Throughout his illustrious career, Umezawa has showcased his talent and passion for medicinal chemistry. He has contributed significantly to advancing pharmaceutical research and development in Japan. Notably, Umezawa has worked with esteemed organizations such as Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai and Nippon Kayaku Kabushiki Kaisha.
Collaborations:
Umezawa's collaborations have been instrumental in his success as an inventor and innovator. Two notable coworkers who have shared his journey are Tomio Takeuchi and Sumio Umezawa. These collaborative efforts have enhanced the quality and impact of their research, further benefiting the field of medicinal chemistry.
Conclusion:
Hamao Umezawa's immense contributions to the field of medicinal chemistry are evident through his numerous patents and groundbreaking inventions. His novel compounds and derivatives have paved the way for innovative therapeutic treatments, offering hope for those suffering from disorders related to alpha and beta neuronal activities. Umezawa's career highlights and collaborations underscore his dedication to advancing the field and leaving a lasting impact on the pharmaceutical industry. Tokyo, Japan owes much of its progress in medicinal chemistry to this visionary inventor, Hamao Umezawa.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile